BIFIDOBACTERIUM/LACTOBACILLUS/STREPTOCOCCUS
Approved January 2016 P&T Committee Meeting.
VSL #3 should be avoided in neutropenic patients.
Approved January 2016 P&T Committee Meeting.
VSL #3 should be avoided in neutropenic patients.